Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response

Amyloid light chain (AL) amyloidosis is a systemic disease characterised by the aggregation of misfolded immunoglobulin light chain (LC), predominantly in the heart and kidneys, causing organ failure. If untreated, the median survival of patients with cardiac AL amyloidosis is 6 months from the onse...

Descripción completa

Detalles Bibliográficos
Autores principales: Grogan, Martha, Dispenzieri, Angela, Gertz, Morie A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566095/
https://www.ncbi.nlm.nih.gov/pubmed/28456755
http://dx.doi.org/10.1136/heartjnl-2016-310704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566095/
https://www.ncbi.nlm.nih.gov/pubmed/28456755
http://dx.doi.org/10.1136/heartjnl-2016-310704

Ejemplares similares